Promega, J3312, FcγRIIb aAPC/CHO-K1 Cells and aAPC/CHO-K1 Cells

Measure Potency and Stability of FcγRIIb Crosslinking-Dependent and -Independent Agonist Antibodies
Use with ICOS and CD28 bioassays to provide activation of TCR/CD3 complex on effector cells and crosslink antibodies
Measure FcγRIIb crosslinking dependence of agonist antibodies that stimulate T cell activation
Mechanism-of-action-based
Specifications：
FcγRIIb aAPC/CHO-K1 (CPM) J325A 2 × 1ml
FcγRIIb aAPC/CHO-K1 Cells J326A 1 × 0.5ml
Ham's F-12 Medium J123A 1 × 25ml
FcγRIIb aAPC/CHO-K1 Cells J326A 5 × 0.5ml
Ham's F-12 Medium J123A 5 × 25ml
aAPC/CHO-K1 Cells (CPM) J119B 2 × 1ml
aAPC/CHO-K1 Cells J119A 1 × 0.5ml
Ham's F-12 Medium J123A 1 × 25ml
aAPC/CHO-K1 Cells J119A 5 × 0.5ml
Ham's F-12 Medium J123A 5 × 25ml